DURHAM, N.C. -- A common human virus may prove useful in attacking the deadliest form of brain tumors, according to study conducted by researchers at Duke’s Preston Robert Tisch Brain Tumor Center. The researchers said the finding is an important step in developing a vaccine that can attack the tumors by enlisting the help of the body’s immune system.
